KKR To Acquire Controlling Stake In India's Healthcare Global Enterprises For $400 Mln

KKR, one of the world's preeminent global investment firms, has announced it will acquire a controlling stake in India's largest oncology hospital chain, Healthcare Global Enterprises (HCG), for $400 million. The transaction entails KKR acquiring up to 54% equity from CVC Asia V at INR 445 per share and an open offer to buy more shares from public shareholders. On completion, KKR will own 54-77% equity in HCG. The founder of HCG, Dr. BS Ajaikumar, will become Non-Executive Chairman to oversee clinical excellence and R&D. This investment represents KKR's continued bet on India's healthcare sector, with the goal of enhancing HCG's capabilities and growing imperative oncology services nationwide.

 

Source: Business Wire